There are many factors that can impact our eyesight, but one common source of vision loss centers on a blockage in the major vein in the eyeball, which prevents it from draining properly and damages ...
Considering this knowledge of the retina, the investigators conducted a study in which the goals were to detect and quantify ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Eylea HD improved vision with extended dosing intervals ...
NEW YORK, July 30 (Reuters) - Roche Holding AG's eye disease drug Lucentis proved effective in helping to improve vision in patients suffering from a condition known as central retinal vein occlusion, ...
GlobalData on MSN
FDA approves Celltrion’s Eydenzelt for eye diseases
Eydenzelt is a vascular endothelial growth factor inhibitor referencing Eylea, which is jointly developed by Regeneron ...
Nordic Pharma, Inc., a subsidiary of Nordic Group B.V., will be featuring LACRIFILL Canalicular Gel, a novel therapy for dry eye symptoms, at the American Academy of Ophthalmology Annual Meeting in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback